Sunita KS Singh, MD MSc FRCPC
University Health Network, Toronto General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sunita KS Singh, MD MSc FRCPC as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:50 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05715814 · meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsisUniversity Health Network, Toronto · recruiting · Peritoneal Dialysis Complication, End Stage Kidney Disease, Sodium-glucose Co-transporter-2 Inhibitors · principal investigator
- Ph3NCT04965935 · Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant RecipientsUniversity Health Network, Toronto · completed · Kidney Transplant Recipients, Post-transplant Diabetes Mellitus, Type 2 Diabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.